Formulated Solutions Poised for Continued Growth as Pharmaceutical Companies Seek CDMOs in Target Markets
Due to a variety of macroeconomic conditions impacting manufacturing and global supply chains, pharmaceutical companies are being forced to navigate rising costs and a high degree of uncertainty. As a result, many are finding it in their best interest to partner with contract development and manufacturing organisations (CDMOs) in their desired markets to shorten the supply chain, streamline operations and reduce turn time and risk.
Formulated Solutions said that it has redefined the pharmaceutical and self-directed consumer healthcare experience for 24 years through creativity and innovation. As it continues to deliver for its global partners as a world-class CDMO, it added that it was stepping up its game with the acquisition of a new FDA-approved aerosol, bag-on-valve (BoV) and liquid filling facility.
